We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+19.44%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.38B
AUM Growth
-$27.3M
Cap. Flow
-$219M
Cap. Flow %
-9.21%
Top 10 Hldgs %
39.28%
Holding
114
New
41
Increased
19
Reduced
15
Closed
25

Top Buys

Rank Stock Value
1
BHVN icon
Biohaven
BHVN
+$53.5M
2
T icon
AT&T
T
+$52.8M
3
NKE icon
Nike
NKE
+$50.1M
4
WYNN icon
Wynn Resorts
WYNN
+$50.1M
5
FIS icon
Fidelity National Information Services
FIS
+$49.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$89.1M
2
DIS icon
Walt Disney
DIS
+$87.4M
3
AMZN icon
Amazon
AMZN
+$82.9M
4
IQV icon
IQVIA
IQV
+$71.9M
5
GPN icon
Global Payments
GPN
+$71.2M

Sector Composition

Rank Sector Weight
1 Healthcare 46.26%
2 Consumer Discretionary 16.29%
3 Industrials 12.13%
4 Consumer Staples 8.08%
5 Technology 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
26
Ultragenyx Pharmaceutical
RARE
$2.55B
$37.9M 1.59%
817,171
+728,231
+819% +$28.6M
KDNY
27
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$37.9M 1.59%
1,444,830
+54,830
+4% +$1.21M
CEG icon
28
Constellation Energy
CEG
$96.4B
$37.2M 1.56%
+431,969
New +$38.9M
TERN
29
DELISTED
Terns Pharmaceuticals
TERN
$35.1M 1.47%
+3,448,275
New +$23M
AMD icon
30
Advanced Micro Devices
AMD
$789B
$31.3M 1.32%
+483,756
New +$31.9M
FULC icon
31
Fulcrum Therapeutics
FULC
$297M
$31.1M 1.31%
4,274,803
+746,803
+21% +$4.87M
XLE icon
32
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$30M 1.26%
+685,140
New +$29.8M
META icon
33
Meta Platforms (Facebook)
META
$1.51T
$29.6M 1.24%
246,259
-252,031
-51% -$29.6M
ORCL icon
34
Oracle
ORCL
$423B
$29.3M 1.23%
+358,313
New +$27.2M
KZR
35
DELISTED
Kezar Life Sciences
KZR
$24.7M 1.04%
350,426
+22,874
+7% +$1.7M
GFL icon
36
GFL Environmental
GFL
$14.9B
$22M 0.93%
753,818
– –
PROK icon
37
ProKidney
PROK
$337M
$21.9M 0.92%
3,193,175
– –
MCK icon
38
McKesson
MCK
$101B
$21.8M 0.92%
58,108
-46,742
-45% -$17.4M
COGT icon
39
Cogent Biosciences
COGT
$7.24B
$20.9M 0.88%
1,811,396
-51,204
-3% -$635K
COR icon
40
Cencora
COR
$61.2B
$20.7M 0.87%
124,658
-217,121
-64% -$34.3M
AGIO icon
41
Agios Pharmaceuticals
AGIO
$1.93B
$19.3M 0.81%
685,772
-273,442
-29% -$7.71M
MRNS
42
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$19.2M 0.81%
4,822,995
+1,285,295
+36% +$6.32M
PNT
43
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$19.2M 0.8%
2,627,000
+296,098
+13% +$2.2M
DFS
44
DELISTED
Discover Financial Services
DFS
$16.3M 0.69%
+166,809
New +$16.8M
ELV icon
45
Elevance Health
ELV
$85.5B
$14.9M 0.62%
+28,971
New +$14.7M
NVDA icon
46
NVIDIA
NVDA
$5.42T
$12.8M 0.54%
+873,580
New +$12.8M
PRTA icon
47
Prothena Corp
PRTA
$459M
$12.4M 0.52%
206,448
-110,083
-35% -$6.45M
ROST icon
48
Ross Stores
ROST
$81.9B
$12.2M 0.51%
+105,040
New +$10.7M
EYPT icon
49
EyePoint Inc
EYPT
$1.2B
$11.7M 0.49%
3,347,897
+114,300
+4% +$504K
ORIC icon
50
Oric Pharmaceuticals
ORIC
$1.4B
$11.2M 0.47%
1,902,643
– –
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Suvretta Capital Management held 114 positions worth $2.38B, down 1.1% from $2.41B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Suvretta Capital Management withdrew a net $219M in Q4 2022, closing 25 positions and reducing 15 holdings. Its most notable exit was Microsoft, an estimated $89.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Suvretta Capital Management opened a new position in AT&T worth $54.3M.

  • Suvretta Capital Management's largest Q4 2022 buy was AT&T: 2,951,900 shares worth $54.3M.
  • Suvretta Capital Management added most to Biohaven in Q4 2022, an estimated $53.5M increase.
  • Suvretta Capital Management's biggest Q4 2022 reduction was IQVIA, cutting an estimated $71.9M.
  • Suvretta Capital Management fully exited Microsoft in Q4 2022, selling an estimated $89.1M.
  • Suvretta Capital Management's ten largest holdings make up 39% of its $2.38B portfolio in Q4 2022.
  • Suvretta Capital Management opened 41 new positions and closed 25 in Q4 2022.
  • Suvretta Capital Management's portfolio value fell 1.1% quarter-over-quarter to $2.38B.

Based on Suvretta Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.